A week before the "http://www.mihealthforum.com/" MIHealth forum on innovation and management of health, which will be held in Barcelona, Dr. Jaume Reventós, head of the Research Unit in Biomedicine and Translational Oncology group at Vall d’Hebron Institute of Research (VHIR), has talked about his experience as a director of "http://www.transbiomed.net/index.php?lang=es" Transbiomed, the first spin-off of VHIR, in two reports published in "http://www.vhir.org/global/pdf/noticies/el%20bistur%C3%AD%20tambi%C3%A9n%20emprende.pdf" "http://www.vhir.org/global/pdf/noticies/el%20bistur%C3%AD%20tambi%C3%A9n%20emprende.pdf" El País and "http://www.vhir.org/global/pdf/noticies/del%20lab%20a%20la%20comercialitzacio.pdf" El Periódico.The creation of this company, aimed at developing medical diagnostic devices, wasn’t easy because the public administration didn’t understand its potential, Dr. Reventós reports. Nonetheless, the context is changing, despite the investment in these projects is far away from countries such as the United States and Canada: “Crisis should not be an obstacle to see the opportunity for change in economics strategy. There are alternatives to the building sector”, assures in El Periódico. And continues in El País: “Starting this type of projects worths for many reasons. As a professional, it is an appreciated different way of research which solves a real problem. Economically speaking, it is never worthy at the beginning”.Transbiomed was founded in 2007 and started its activity thanks to a risk capital investment. Now, from the 26th to the 28th of June, Barcelona will be the center of discussion and sharing of experiences in clinical innovation and new models of health management with the aim to improve the health system, the attention to patients, and to attract private investors to make it possible. VHIR’s director, Dr. Joan X. Comella, is a member of the scientific committee of MIHealth, and the head of knowledge transfer and innovation at VHIR, Raquel Egea, will be a leader session in this congress that will take place at Palau de Congressos de Barcelona.